If you’ve only heard one thing about Peter Thiel (and many have heard nothing at all) it is that he is a believer in the power of young blood. The tech multibillionaire and founding investor of the surveillance company Palantir is a public advocate of parabiosis, an experimental field of biology investigating whether transfusions of blood from young people to older ones can stall or even reverse ageing.
Already a subscriber? Log in
Get 10 issues
for $10
Subscribe to The Spectator Australia today for the next 10 magazine issues, plus full online access, for just $10.
- Delivery of the weekly magazine
- Unlimited access to spectator.com.au and app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in